CLINICAL TRIALS PROFILE FOR VONOPRAZAN FUMARATE

All Clinical Trials for vonoprazan fumarate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04901117 ↗	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days	Not yet recruiting	Heze Municipal 3rd people's hospital	Phase 4	2021-06-01	The researchers collect treatment-naive H.pylori-positive patients from the outpatient clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates, patient compliance and cost-effectiveness index of each group.
NCT04901117 ↗	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days	Not yet recruiting	Jining No.2 People's Hospital	Phase 4	2021-06-01	The researchers collect treatment-naive H.pylori-positive patients from the outpatient clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates, patient compliance and cost-effectiveness index of each group.
NCT04901117 ↗	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days	Not yet recruiting	Maternity and Child Care Health Center of Dezhou	Phase 4	2021-06-01	The researchers collect treatment-naive H.pylori-positive patients from the outpatient clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates, patient compliance and cost-effectiveness index of each group.
NCT04901117 ↗	Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days	Not yet recruiting	PKUcare luzhong hospital	Phase 4	2021-06-01	The researchers collect treatment-naive H.pylori-positive patients from the outpatient clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates, patient compliance and cost-effectiveness index of each group.

Clinical Trial Conditions for vonoprazan fumarate

Condition Name

Condition Name for vonoprazan fumarate
Intervention	Trials
Helicobacter Pylori Infection	4
Helicobacter Pylori Eradication Rate	2
Helicobacter Pylori	1

Condition MeSH

Condition MeSH for vonoprazan fumarate
Intervention	Trials
Infections	1
Helicobacter Infections	1

Clinical Trial Locations for vonoprazan fumarate

Trials by Country

Trials by Country for vonoprazan fumarate
Location	Trials
China	5

Clinical Trial Progress for vonoprazan fumarate

Clinical Trial Phase

Clinical Trial Phase for vonoprazan fumarate
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	1
N/A	1

Clinical Trial Status

Clinical Trial Status for vonoprazan fumarate
Clinical Trial Phase	Trials
Not yet recruiting	5
Recruiting	2

Clinical Trial Sponsors for vonoprazan fumarate

Sponsor Name

Sponsor Name for vonoprazan fumarate
Sponsor	Trials
Shandong University	2
Sixth Affiliated Hospital, Sun Yat-sen University	2
The First Affiliated Hospital of Nanchang University	2

Sponsor Type

Sponsor Type for vonoprazan fumarate
Sponsor	Trials
Other	36